GoHealth Q4 GAAP EPS $(0.22) May Not Be Comparable To $2.73 Estimate, Sales $276.70M Miss $363.88M Estimate
Portfolio Pulse from Benzinga Newsdesk
GoHealth (NASDAQ:GOCO) reported Q4 GAAP EPS of $(0.22), missing the consensus estimate of $2.73 by 108.06%, and sales of $276.70M, missing the estimate of $363.88M by 23.96%. Despite these misses, the company saw a significant increase over the previous year, with losses improving by 96.86% and sales increasing by 298.84%.
March 14, 2024 | 10:05 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
GoHealth reported significant misses in Q4 earnings and sales compared to analyst estimates but showed substantial improvement over the previous year.
The substantial misses in both earnings per share and sales compared to analyst expectations are likely to negatively impact investor sentiment and the stock price in the short term. However, the significant year-over-year improvements in reducing losses and increasing sales may provide some counterbalance to the negative impact.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100